Literature DB >> 14625376

Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model.

Julie L Lavoie1, Martin D Cassell, Kenneth W Gross, Curt D Sigmund.   

Abstract

Immunoreactive renin has been reported in the hypothalamus and cerebellar cortex in the rodent brain and in neurons in all areas of the human brain. Despite these observations and the clear documentation of the expression of the other renin-angiotensin system genes in the brain, the notion that renin is endogenously expressed in the brain remains very controversial and undefined. This controversy no doubt arises because the level of renin expression in the brain is below the detection threshold of most standard assays. A transgenic mouse expressing enhanced green fluorescence protein (eGFP) under the control of the mouse renin promoter was recently reported. This model expresses eGFP in the kidney, which responds appropriately to both developmental and physiological stimuli. We therefore used eGFP as a sensitive marker to identify renin-expressing cells in the brain. We identified eGFP-containing cells in specific areas of the brain, including cerebellum, hippocampus, dorsal motor nucleus of the vagus, inferior olivary nucleus, reticular formation, rostral ventrolateral medulla, central nucleus of the amygdala, lateral parabrachial nucleus, mesencephalic trigeminal nucleus, bed nucleus of stria terminalis, and subfornical organ. By colabeling with neuron- or glia (astrocytes or oligodendrocytes)-specific antisera, we have determined the eGFP-positive cells to be mainly neuronal. These findings therefore strongly support the primary expression of renin mRNA in the brain in regions controlling cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14625376     DOI: 10.1152/physiolgenomics.00131.2003

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  37 in total

Review 1.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Neuron- or glial-specific ablation of secreted renin does not affect renal renin, baseline arterial pressure, or metabolism.

Authors:  Di Xu; Giulianna R Borges; Deborah R Davis; Khristofor Agassandian; Maria Luisa S Sequeira Lopez; R Ariel Gomez; Martin D Cassell; Justin L Grobe; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2010-12-28       Impact factor: 3.107

3.  The renin-angiotensin system: it's all in your head.

Authors:  Kelly K Parsons; Thomas M Coffman
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 4.  The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence.

Authors:  Michael J Glass
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

Review 5.  Subcellular characteristics of functional intracellular renin-angiotensin systems.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey
Journal:  Peptides       Date:  2012-09-29       Impact factor: 3.750

6.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 7.  Molecular evidence of tissue renin-angiotensin systems: a focus on the brain.

Authors:  Koji Sakai; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

8.  Selective Deletion of the Brain-Specific Isoform of Renin Causes Neurogenic Hypertension.

Authors:  Keisuke Shinohara; Xuebo Liu; Donald A Morgan; Deborah R Davis; Maria Luisa S Sequeira-Lopez; Martin D Cassell; Justin L Grobe; Kamal Rahmouni; Curt D Sigmund
Journal:  Hypertension       Date:  2016-10-17       Impact factor: 10.190

Review 9.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

10.  Activation of the renin-angiotensin system, specifically in the subfornical organ is sufficient to induce fluid intake.

Authors:  Jeffrey P Coble; Martin D Cassell; Deborah R Davis; Justin L Grobe; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.